Tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease-associated hepatocellular carcinoma

ID Vachliotis, I Valsamidis, SA Polyzos - Cancers, 2023 - mdpi.com
Simple Summary The prevalence of nonalcoholic fatty liver disease (NAFLD)-associated
hepatocellular carcinoma (HCC) is rapidly increasing, following the growing prevalence of …

Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration

J Kountouras, M Boziki, E Kazakos, P Theotokis… - Neurochemistry …, 2024 - Elsevier
Both Helicobacter pylori (H. pylori) infection and metabolic syndrome (MetS) are highly
prevalent worldwide. The emergence of relevant research suggesting a pathogenic linkage …

非酒精性脂肪性肝病更名: 从代谢功能障碍相关脂肪肝异质性到“同病异治”

刘嘉玲, 孙劲晖 - 中国中西医结合消化杂志, 2024 - zxyxh.whuhzzs.com
关于非酒精性脂肪性肝病(NAFLD) 更名为代谢功能障碍相关脂肪肝(MAFLD/MASLD)
近两年来争议不断, 期间大数据研究结果证明了NAFLD 的时代局限性. 重新审视命名法 …

Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseases

M Doulberis, A Papaefthymiou, SA Polyzos… - Frontiers in …, 2024 - frontiersin.org
Helicobacter pylori, a widely renowned bacterium, has recently gained attention owing to its
potential impact on extragastric health. The emergence of research linking H. pylori infection …

Renaming non-alcoholic fatty liver disease: from metabolic dysfunction-associated fatty liver heterogeneity to" different treatment for the same disease"

LIU Jialing, SUN Jinhui - Chin J Integr Tradit West Med Dig, 2024 - zxyxhen.whuhzzs.com
The renaming of non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-
associated fatty/steatotic liver disease (MAFLD/MAFLD) has been controversial for the last …